<code id='958C8A0601'></code><style id='958C8A0601'></style>
    • <acronym id='958C8A0601'></acronym>
      <center id='958C8A0601'><center id='958C8A0601'><tfoot id='958C8A0601'></tfoot></center><abbr id='958C8A0601'><dir id='958C8A0601'><tfoot id='958C8A0601'></tfoot><noframes id='958C8A0601'>

    • <optgroup id='958C8A0601'><strike id='958C8A0601'><sup id='958C8A0601'></sup></strike><code id='958C8A0601'></code></optgroup>
        1. <b id='958C8A0601'><label id='958C8A0601'><select id='958C8A0601'><dt id='958C8A0601'><span id='958C8A0601'></span></dt></select></label></b><u id='958C8A0601'></u>
          <i id='958C8A0601'><strike id='958C8A0601'><tt id='958C8A0601'><pre id='958C8A0601'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:82
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          An interview with Robert F. Kennedy Jr. on vaccines
          An interview with Robert F. Kennedy Jr. on vaccines

          RobertF.KennedyJr.talkswithreportersinthelobbyofTrumpTowerinJanuary2017.EvanVucci/APIntheearlydaysof

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Johnson & Johnson sued for allegedly overpaying for workers' drugs

          ChrisO'Meara/APJohnson&Johnsonfacesaconsequentialnewclassactionlawsuit—notinitsroleasamanuf